6 ms·
They also picked very short booster dose times (3 or 4 weeks) to get study results quicker. Usually you have a longer pause, which gives somewhat better result
by BurningFrog 6y ago
They also picked very short booster dose times (3 or 4 weeks) to get study results quicker.
Usually you have a longer pause, which gives somewhat better results.
Now those numbers are treated as sacred by so many.
- throwaway189262 6y agoIt is unfortunate. You can't even avoid downvotes in a fairly rational place like HN :) . I've been following the vaccine development pretty closely and everything looks like a "this can't fail" mentality. People need to realize that it's rational to ask if we really need the dose this high and really need a booster because if we find out we don't, it could double or even quadruple our vaccine supply. That could save half a million lives. It's good to ask questions like this especially when there's a massive worldwide vaccine shortage
- Guthur 6y agoGiven HN propensity to bash corporations I'm surprised this is not seen as a way to double or triple profits :)
- throwaway189262 6y agoIndeed. But to bash the large corpos, when medical staff figured out they could get an extra dose from most vials the drug companies immediately reduced their shipment contract requirements accordingly. Pretty scummy.
- Espressosaurus 6y agoThis is a case of "let's go with what works, because the downsides are worse", and we can simultaneously kick off studies of other approaches. When those are proven out (or not) changes in the protocols can be applied then. Blindly changing the protocols without proper controls/studies done in widescale deployment and hoping for the best is a great way to screw things up.
- mlyle 6y agoA good way to do this: enroll people who have had dose 1 but not dose 2. Give half of them dose 2 and half placebo at the normal interval; then at double interval give those that hadn't gotten dose 2 yet their second dose. This can cut a month off the trial. I also think you don't need a full 4 months of data for this-- just enough to show not-gross-inferiority.
- tw04 6y agoWho would volunteer for that study? It would be horribly unethical to give people a placebo who didn't volunteer.
- mlyle 6y agoI'd volunteer. I'm 41 and about to be up for my turn as an educator. I feel OK about the mitigations in my classroom and my overall level of risk, and a bit guilty about getting my dose earlier than most; a 50-50 chance of delaying my second dose doesn't appreciably make the risk picture worse. If my second dose was delayed, odds are I'd end up with better long term immunity, too, even though my risk in the intermediate period would be higher. > It would be horribly unethical to give people a placebo who didn't volunteer. No shit. That's why I said "enroll" -- this includes getting consent. I suspect finding 20k people to volunteer out of the ~10M dosed per week wouldn't be that hard.
- renewiltord 6y agoI’d volunteer for a challenge trial, so obviously I’d volunteer for this.
- skybrian 6y agoWhy not volunteer? One dose is apparently quite protective already. Most likely, there will be little difference which arm of the trial you end up on.
- astura 6y agoI would.
- mxcrossb 6y agoWhy is the development “this can’t fail” but the distribution isn’t? If we cut corners on distribution (and compound that with the real world flaws in the process) and you screw up, it would be a huge disaster. You would complete undermine the public’s faith in vaccines and lockdowns.
- mattmanser 6y agoIt's a gamble the British government are already taking, they decided to extend the time between doses to give me people the first dose sooner. We'll start to see in 8 weeks or so if it was worth it.
- barry-cotter 6y agoIf the vaccine developers fail their companies lose lots of money and their bosses are mad at them. There’s a tiny possibility they might lose their jobs and it certainly won’t look good for promotion purposes. Also, developing vaccines is something they actually know how to do. If civil servants fuck up in ways that delay or prevent progress in fighting COVID there are no consequences. No one gets fired or reprimanded, whether for what they said about masks, preventing home testing, telling the Seattle Flu Study they couldn’t test for COVID in February, fining distillers for making hand sanitizer... And note the US FDA and CDC are at worst only a little worse than the European Medical Authority. Slower at approving more or less everything, like KN95s or the J&J vaccine, but they’re not actively trying to kill people. They’re just making sure they can’t be blamed for approving something unsafe. The people who die as a result of that delay are not their problem.
- Spooky23 6y agoThat’s nonsense government griping. In fact, we had an election and fired all of those decision makers. Rushing through things like KN-95 has consequences. My brother is a firefighter paramedic and found out that 90% of the kn95 masks issued to him were completely defective.
- wwweston 6y ago
- jonstewart 6y agoO Rational, rational, wherefore art thou rational? Deny thy prior and refuse thy game Or if trials not, warranty void of And I’ll no longer make a captious bet.
- WalterBright 6y agoI'd be first in line to get a vaccine even if it was less than 10% effective.
- 4eor0 6y ago“Hindsight is 20/20.” Of all the failures in the system that could have prevented lives, this seems like the least egregious. What people need to realize is politically inclined or no, restricting political involvement to an election every 2-4 years, letting it optimize for fiscal efficiency, not resiliency and reliability, has killed a whole lot more people than extra caution over dosage. None of the general public control drug companies. They could control the government. I’m all in on being a big corp sycophant because the general public are clearly incompetent political agents by enabling a bigger mess than necessary in the first place.
- dkural 6y agoMaybe because HN is rational, and thus doesn't like the factual inaccuracies in your post? 1) There were no adjuvants used 2) Antibody response doesn't linearly correlate with protection. Many vaccines provoke a higher antibody response but much less efficacy compared to the Moderna and Pfizer/BioNTech vaccine. 3) mRNA is an entirely new modality, it's not like people knew before-hand what would work, given point 2. I don't think anyone is arguing that IF the booster is not needed, then we shouldn't double the vaccine supply. Consider the following risk however: There is such a thing called vaccine resistance. A weakly immunized patient becomes a training ground for novel variants of the virus that then starts spreading & vaccine doesn't work.
- Closi 6y agoI don’t think OP claimed any of this, at least in my reading. All of these things are trade offs anyway - a weaker immunised patient might become a training ground for a variant, but a weakly immunised patient might also have a reduced risk of spreading which results in fewer cases and fewer chances for mutations.
- stjohnswarts 6y agoWe can save those experiments for when there isn't 450,000 Americans dead from covid. I prefer the go early go hard approach. There will be a second round of Covid-21, the South African mutated version is proving that.
- _ph_ 6y agoWell, this really can't fail. The challenge was to develop a ready-to market vaccine in the shortest possible time and several companies managed this task. That is why millions are already vaccinated. Yes, you are allowed to ask questions, but why do you assume that all the involved experts at the pharmaceutical companies didn't ask those questions? And as far as I am aware, they did investigate different dosages. So what we got now is their best effort given the many competing requirements. And yes, they might have a bit generous, but only a bit, as higher doses do create stronger side effects. And I am very happy they did, considering the mutations appeared in the meantime and the vaccines are still effective. I am sure, the vaccines are going to be further optimized as more time goes by and especially more data becomes available.
- hitpointdrew 6y ago> but why do you assume that all the involved experts at the pharmaceutical companies didn't ask those questions? Because they have a financial incentive not to ask those.
- BurningFrog 6y ago> why do you assume that all the involved experts at the pharmaceutical companies didn't ask those questions? Pharmaceutical company employees have no power over FDA decisions. > And as far as I am aware, they did investigate different dosages. They did, and the result was that half doses produce as strong an immune response as full doses. This is the basis for this "let's do half doses" argument! The study was done with the bigger dose, and showed 95% protection. So we know that (1) dose A has the same effect as dose B, and (2) dose B provides 95% protection. Obviously (1)+(2) logically implies that using dose A would give twice as many people the same immunity. But logic is not part of the FDA regulatory framework. You have to blindly repeat the protocol of the study, whether it makes sense or not. Whether thousands die or not.
- MereInterest 6y agoInteresting, I hadn't known that. I imagine the short booster dose time also helps in implementation, because an individual gets maximum immunity 6 weeks after the first dose (4 weeks pause + 2 weeks) rather than 28 weeks (6 month pause + 2 weeks) for a longer pause. Having a longer pause to maximize individual immunity might not be the fastest way to maximize population immunity during an ongoing pandemic.
- nicoburns 6y agoI'm not sure about that. Here in the UK we've gone with a 12 week gap precisely because it allows us to vaccinate more of the population more quickly.
- mlyle 6y agoFirst dose gets you to 80% efficacy after about 10 days. If you e.g. produce 1 dose per month, you're way better off giving the doses to ABCDEFABCDEF than AABBCCDDEEFF. Six people are 80% protected after 6 months, instead of 3 people 95% protected after 6 months... assuming that everyone ends up at the same efficacy at the end (which we don't know). But... we know this is probably effective-- probably even more effective after the delayed second dose.. which isn't the same as showing that it's effective in a study.
- MereInterest 6y agoGood point, I hadn't been aware that the first dose was that effective without the booster.
- jerf 6y agoWithout specifically criticizing this vaccine process, I would add that if you start digging into medical research, you will find this is the rule rather than the exception. I've had my own semi-obscure issues I've gone trolling through the literature for assistance with, and one of the things I've found is that you'll find something that is tested; for a specific example, I found some examination of taurine supplementation for heart arrhythmia issues. There were multiple papers that all studied the exact same dosing schedule. This strongly suggests to me that the initial schedule was basically someone thinking for a moment and giving an informed guess about what might work. This is just an observation, not a criticism, because I don't have a better suggestion for what they can do, nor do I particularly believe there is a much better suggestion necessarily. You have to start somewhere. My point is just that you shouldn't overestimate the exact numbers and how much effort was put into exploring all the details. Obviously some things are deeply studied, but most things won't be. This implies that, statistically speaking, there very likely are drugs that were formulated, created, and put into a testing regime that they failed that actually work great, but were just dosed out to the study participants such that the good effects didn't emerge yet, or were dosed on a poor schedule, etc. (Or would have worked great if paired with a hit of grapefruit. [1]) I also wonder how that compares to the number of drugs that were never tested on humans because they failed animal testing, but it turns out that in reality they would have been fine in humans. Just idle musings on life. [1]: https://news.ycombinator.com/item?id=24705855 https://news.ycombinator.com/item?id=24705855
- stjohnswarts 6y agoI think a lot of software developers have swallowed the "be lean all the time" that the projects managers are selling :) . "Good enough is good enough" is another one I hear a lot from PM. Anyway there's something to be said for paying $1000 for that vacuum cleaner that you won't have to replace for 30 years.
- woofie11 6y agoWhich one? That's a serious question. Last time I looked at expensive vacuums, e.g. Dyson discontinued parts after 10 years. It might not break, but you can't buy a roller for 10-year-old models. Shark was way shorter. I found no long-term brands.
- legulere 6y agoThey should be sacred until we have completed studies with other regimens. What we have is a theory but we need to collect data to correctly identify the best timing.
- _ph_ 6y agoWell, these are the numbers we have and which have been confirmed by the proper trials. I am sure, there is more research getting performed to optimize the vaccines, but we fortunately can vaccinate with good results based on these numbers.